Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways

Background/Aims: Oleocanthal (OC), a phenolic compound present in extra virgin olive oil (EVOO), has attracted attention since its discovery for its relevant pharmacological properties in different pathogenic processes, including inflammation. Here, we investigated the involvement of OC in LPS-activ...

Full description

Bibliographic Details
Main Authors: Morena Scotece, Javier Conde, Vanessa Abella, Veronica López, Vera Francisco, Clara Ruiz, Victor Campos, Francisca Lago, Rodolfo Gomez, Jesús Pino, Oreste Gualillo
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-09-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/493840
_version_ 1811340983085826048
author Morena Scotece
Javier Conde
Vanessa Abella
Veronica López
Vera Francisco
Clara Ruiz
Victor Campos
Francisca Lago
Rodolfo Gomez
Jesús Pino
Oreste Gualillo
author_facet Morena Scotece
Javier Conde
Vanessa Abella
Veronica López
Vera Francisco
Clara Ruiz
Victor Campos
Francisca Lago
Rodolfo Gomez
Jesús Pino
Oreste Gualillo
author_sort Morena Scotece
collection DOAJ
description Background/Aims: Oleocanthal (OC), a phenolic compound present in extra virgin olive oil (EVOO), has attracted attention since its discovery for its relevant pharmacological properties in different pathogenic processes, including inflammation. Here, we investigated the involvement of OC in LPS-activated osteoarthritis (OA) human primary chondrocytes. Methods: Human primary chondrocytes were harvested from articular cartilage samples obtained from OA patients. The effects of OC on the viability of chondrocytes were tested by MTT assay. Protein and mRNA expression of several catabolic and pro-inflammatory factors after OC treatment were measured by RT-qPCR and western blot respectively. Moreover, we analysed the NO production by Griess reaction. Finally, several pathways mediators were analysed by western blot. Results: We demonstrated that OC did not have any cytotoxic effect. Oleocanthal inhibited NO production and strongly decreased NOS2 and COX-2 protein and mRNA expression in LPS-activated human primary OA chondrocytes. Interestingly, OC also inhibits MMP-13 and ADAMTS-5. In addition, OC downregulates several pro-inflammatory factors, such as IL-6, IL-8, CCL3, LCN2 and TNF-α induced by LPS in human primary OA chondrocytes. Finally, we demonstrated that OC exerts its effects through the MAPK/P38/NF-kB pathways. Conclusion: These data show that OC is able to block LPS-mediated inflammatory response and MMP-13 and ADAMTS-5 induction in human primary OA chondrocytes via MAPKs/NF-kB pathways, suggesting that OC may be a promising agent for the treatment of inflammation in cartilage and a potential molecule to prevent disease progression by inhibiting metalloproteases and aggrecanases.
first_indexed 2024-04-13T18:50:30Z
format Article
id doaj.art-76fdf11338e44f54b9c2f28d4bc8b9da
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-04-13T18:50:30Z
publishDate 2018-09-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-76fdf11338e44f54b9c2f28d4bc8b9da2022-12-22T02:34:27ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-09-014962414242610.1159/000493840493840Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB PathwaysMorena ScoteceJavier CondeVanessa AbellaVeronica LópezVera FranciscoClara RuizVictor CamposFrancisca LagoRodolfo GomezJesús PinoOreste GualilloBackground/Aims: Oleocanthal (OC), a phenolic compound present in extra virgin olive oil (EVOO), has attracted attention since its discovery for its relevant pharmacological properties in different pathogenic processes, including inflammation. Here, we investigated the involvement of OC in LPS-activated osteoarthritis (OA) human primary chondrocytes. Methods: Human primary chondrocytes were harvested from articular cartilage samples obtained from OA patients. The effects of OC on the viability of chondrocytes were tested by MTT assay. Protein and mRNA expression of several catabolic and pro-inflammatory factors after OC treatment were measured by RT-qPCR and western blot respectively. Moreover, we analysed the NO production by Griess reaction. Finally, several pathways mediators were analysed by western blot. Results: We demonstrated that OC did not have any cytotoxic effect. Oleocanthal inhibited NO production and strongly decreased NOS2 and COX-2 protein and mRNA expression in LPS-activated human primary OA chondrocytes. Interestingly, OC also inhibits MMP-13 and ADAMTS-5. In addition, OC downregulates several pro-inflammatory factors, such as IL-6, IL-8, CCL3, LCN2 and TNF-α induced by LPS in human primary OA chondrocytes. Finally, we demonstrated that OC exerts its effects through the MAPK/P38/NF-kB pathways. Conclusion: These data show that OC is able to block LPS-mediated inflammatory response and MMP-13 and ADAMTS-5 induction in human primary OA chondrocytes via MAPKs/NF-kB pathways, suggesting that OC may be a promising agent for the treatment of inflammation in cartilage and a potential molecule to prevent disease progression by inhibiting metalloproteases and aggrecanases.https://www.karger.com/Article/FullText/493840OleocanthalChondrocytesPhenolic componentInflammationOsteoarthritis
spellingShingle Morena Scotece
Javier Conde
Vanessa Abella
Veronica López
Vera Francisco
Clara Ruiz
Victor Campos
Francisca Lago
Rodolfo Gomez
Jesús Pino
Oreste Gualillo
Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways
Cellular Physiology and Biochemistry
Oleocanthal
Chondrocytes
Phenolic component
Inflammation
Osteoarthritis
title Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways
title_full Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways
title_fullStr Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways
title_full_unstemmed Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways
title_short Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways
title_sort oleocanthal inhibits catabolic and inflammatory mediators in lps activated human primary osteoarthritis oa chondrocytes through mapks nf κb pathways
topic Oleocanthal
Chondrocytes
Phenolic component
Inflammation
Osteoarthritis
url https://www.karger.com/Article/FullText/493840
work_keys_str_mv AT morenascotece oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT javierconde oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT vanessaabella oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT veronicalopez oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT verafrancisco oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT clararuiz oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT victorcampos oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT franciscalago oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT rodolfogomez oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT jesuspino oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways
AT orestegualillo oleocanthalinhibitscatabolicandinflammatorymediatorsinlpsactivatedhumanprimaryosteoarthritisoachondrocytesthroughmapksnfkbpathways